September 9, 2020, 09:02 +06

Photo source, OXFORD UNIVERSITY
Photo caption,
A volunteer taking the Oxford vaccine
The coronavirus vaccine, which was being tested by Oxford University and the pharmaceutical company AstraZeneca, has been suspended after one participant fell ill.
AstraZeneca described such breaks as part of a "routine" work due to an unexplained illness.
The result of this tick is being watched all over the world.
The AstraZeneca-Oxford University vaccine is seen as one of the most promising coronavirus vaccines in the world.
With the successful completion of the first and second phase tests, it is expected that this vaccine will be the first to hit the market.
The third phase is being tested on 30,000 participants across the United States, the United Kingdom, Brazil and South Africa. In the third stage of the test, thousands of people are tested. Many times it can last for several years.